Efficacy of high-dose intravenous immunoglobulin in severe and critical COVID-19: A retrospective cohort study

BACKGROUND: Various immunomodulatory therapies have been explored to manage the dysregulated immune response seen in severe COVID-19 infection. The objective of this study was to evaluate the efficacy of intravenous immunoglobulin (IVIG) in severe and critical COVID-19 disease. METHODS: This retrosp...

Descripción completa

Detalles Bibliográficos
Autores principales: Aggarwal, Ritesh, Dewan, Arun, Pandey, Ankita, Trehan, Nikita, Majid, Muhammad Aamir
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8825318/
https://www.ncbi.nlm.nih.gov/pubmed/35168081
http://dx.doi.org/10.1016/j.intimp.2022.108615

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8825318/
https://www.ncbi.nlm.nih.gov/pubmed/35168081
http://dx.doi.org/10.1016/j.intimp.2022.108615

Ejemplares similares